Elicio Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.15

+0.09 (+2.94%)

As of Aug 15, 2:14 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +917.1% upside

Low Target $22.50

Average Target $32.04

High Target $35.39

Current Price $3.15

Current
$3.15

Target
$32.04

$22.50 $32.04 avg $35.39

Scenario Analysis

Bear Case

$22.50

614.3%

Low target

Base Case

$32.04

+917.1%

Avg target

Bull Case

$35.39

+1,023.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$16.00

-80.3% from high

52-Week Low

$2.66

+18.4% from low

Target vs 52W High

$32.04

+100.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%